Keywords: Qiagen, Ipsogen, Molecular diagnostics, M&A

Qiagen to buy 61% stake in Ipsogen, aiming to take full control of the molecular diagnostics firm

Article | 10 July 2011

Netherlands company Qiagen (Nasdaq: QGEN) has entered into binding agreements with a group of major shareholders of Marseille, France-based Ipsogen ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Qiagen

Ipsogen

Go to company listing